ICU MEDICAL INC/DE (ICUI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 900M 1.8B 2.7B Q4 '08: 204.7M Q1 '09: 214.4M Q2 '09: 219.2M Q3 '09: 218.4M Q4 '09: 229M Q1 '10: 239M Q2 '10: 254.5M Q3 '10: 276.2M Q4 '10: 284.1M Q1 '11: 291.2M Q2 '11: 300.1M Q3 '11: 300.9M Q4 '11: 302.2M Q1 '12: 306.2M Q2 '12: 305.7M Q3 '12: 310.7M Q4 '12: 316.9M Q1 '13: 315.7M Q2 '13: 317M Q3 '13: 318.4M Q4 '13: 313.7M Q1 '14: 312.6M Q2 '14: 312.7M Q3 '14: 307.3M Q4 '14: 309.3M Q1 '15: 317.5M Q2 '15: 322.6M Q3 '15: 331.2M Q4 '15: 341.7M Q1 '16: 350M Q2 '16: 363M Q3 '16: 374.1M Q4 '16: 379.4M Q1 '17: 537.3M Q2 '17: 772M Q3 '17: 1B Q4 '17: 1.3B Q1 '18: 1.4B Q2 '18: 1.4B Q3 '18: 1.4B Q4 '18: 1.4B Q1 '19: 1.4B Q2 '19: 1.3B Q3 '19: 1.3B Q4 '19: 1.3B Q1 '20: 1.3B Q2 '20: 1.3B Q3 '20: 1.3B Q4 '20: 1.3B Q1 '21: 1.3B Q2 '21: 1.3B Q3 '21: 1.3B Q4 '21: 1.3B Q1 '22: 1.5B Q2 '22: 1.8B Q3 '22: 2B Q4 '22: 2.3B Q1 '23: 2.3B Q2 '23: 2.3B Q3 '23: 2.2B Q4 '23: 2.3B Q1 '24: 2.3B Q2 '24: 2.3B Q3 '24: 2.3B Q4 '24: 2.4B Q1 '25: 2.4B Q2 '25: 2.4B Q3 '25: 2.3B Q4 '25: 2.2B Q1 '26: 2.2B Q2 '26: 2.2B Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit TTM

0 300M 600M 900M Q4 '08: 89.8M Q1 '09: 98.6M Q2 '09: 103.6M Q3 '09: 103.7M Q4 '09: 106.3M Q1 '10: 106.6M Q2 '10: 113M Q3 '10: 122M Q4 '10: 130.1M Q1 '11: 137.8M Q2 '11: 141.9M Q3 '11: 143.4M Q4 '11: 142.4M Q1 '12: 142.7M Q2 '12: 145.6M Q3 '12: 150.7M Q4 '12: 156.5M Q1 '13: 158.3M Q2 '13: 157.3M Q3 '13: 157.6M Q4 '13: 154.7M Q1 '14: 154M Q2 '14: 153.5M Q3 '14: 150.7M Q4 '14: 151.4M Q1 '15: 157.9M Q2 '15: 164.1M Q3 '15: 172.2M Q4 '15: 180.8M Q1 '16: 187.5M Q2 '16: 193.9M Q3 '16: 198.9M Q4 '16: 201.4M Q1 '17: 241.1M Q2 '17: 279M Q3 '17: 339.4M Q4 '17: 426.1M Q1 '18: 486.2M Q2 '18: 549.9M Q3 '18: 572.9M Q4 '18: 570M Q1 '19: 556.3M Q2 '19: 508.4M Q3 '19: 492.4M Q4 '19: 471.9M Q1 '20: 458M Q2 '20: 460.4M Q3 '20: 455.8M Q4 '20: 461.5M Q1 '21: 452.8M Q2 '21: 470M Q3 '21: 483.9M Q4 '21: 491.5M Q1 '22: 547.6M Q2 '22: 591.7M Q3 '22: 650.3M Q4 '22: 697.8M Q1 '23: 721M Q2 '23: 745.7M Q3 '23: 743.2M Q4 '23: 739.9M Q1 '24: 733.1M Q2 '24: 748.2M Q3 '24: 769.1M Q4 '24: 824.8M Q1 '25: 849.6M Q2 '25: 850.3M Q3 '25: 846.3M Q4 '25: 822M Q1 '26: 818.2M Q2 '26: 845.1M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating Income TTM

-50M 0 50M 100M 150M Q4 '08: 31.4M Q1 '09: 39.5M Q2 '09: 42.5M Q3 '09: 39.6M Q4 '09: 35.4M Q1 '10: 31.1M Q2 '10: 34.2M Q3 '10: 41.2M Q4 '10: 47.7M Q1 '11: 53.5M Q2 '11: 55.7M Q3 '11: 54.4M Q4 '11: 65.2M Q1 '12: 64.4M Q2 '12: 64M Q3 '12: 68.2M Q4 '12: 61.3M Q1 '13: 61.9M Q2 '13: 59.3M Q3 '13: 57.2M Q4 '13: 51.9M Q1 '14: 49.8M Q2 '14: 47.5M Q3 '14: 40.5M Q4 '14: 39M Q1 '15: 40.1M Q2 '15: 51.8M Q3 '15: 68.1M Q4 '15: 68.6M Q1 '16: 81.5M Q2 '16: 84M Q3 '16: 81.7M Q4 '16: 82.9M Q1 '17: 42M Q2 '17: -16.7M Q3 '17: -42.8M Q4 '17: -13.3M Q1 '18: 8.6M Q2 '18: 76.3M Q3 '18: 82.2M Q4 '19: 107.4M Q1 '20: 103M Q2 '20: 96.3M Q3 '20: 89M Q4 '20: 98.2M Q1 '21: 98.7M Q2 '21: 113.6M Q3 '21: 126.4M Q4 '21: 123.2M Q1 '22: 54.5M Q2 '22: 20M Q3 '22: -18.9M Q4 '22: -42.9M Q1 '23: 8.7M Q2 '23: 11.5M Q3 '23: 34.8M Q4 '24: 43M Q1 '25: 66.5M Q2 '25: 69.4M Q3 '25: 74.9M Q4 '25: 42.8M Q1 '26: 43.5M Q2 '26: 72.1M Q2 '10 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '21 Q2 '23 Q2 '26

Net Income TTM

-150M -100M -50M 0 50M 100M 150M Q4 '08: 24.3M Q1 '09: 28.5M Q2 '09: 29.4M Q3 '09: 28.1M Q4 '09: 25M Q1 '10: 22.2M Q2 '10: 24.1M Q3 '10: 26.8M Q4 '10: 30.6M Q1 '11: 34.4M Q2 '11: 36.2M Q3 '11: 36.5M Q4 '11: 44.7M Q1 '12: 44.2M Q2 '12: 43.9M Q3 '12: 46.8M Q4 '12: 41.3M Q1 '13: 42.4M Q2 '13: 40.6M Q3 '13: 39.4M Q4 '13: 40.4M Q1 '14: 38.4M Q2 '14: 36.9M Q3 '14: 32.3M Q4 '14: 26.3M Q1 '15: 29.4M Q2 '15: 37.1M Q3 '15: 46.9M Q4 '15: 45M Q1 '16: 53.5M Q2 '16: 56.5M Q3 '16: 59M Q4 '16: 63.1M Q1 '17: 100.8M Q2 '17: 47.1M Q3 '17: 28.5M Q4 '17: 68.6M Q1 '18: 17.7M Q2 '18: 85.8M Q3 '18: 85.9M Q4 '18: 28.8M Q1 '19: 54.9M Q2 '19: 46.7M Q3 '19: 73M Q4 '19: 101M Q1 '20: 86.9M Q2 '20: 82.9M Q3 '20: 81.4M Q4 '20: 86.9M Q1 '21: 93.8M Q2 '21: 103.3M Q3 '21: 109.4M Q4 '21: 103.1M Q1 '22: 41.3M Q2 '22: 5.5M Q3 '22: -35.4M Q4 '22: -74.3M Q1 '23: -46M Q2 '23: -48.5M Q3 '23: -31.4M Q4 '23: -29.7M Q1 '24: -59.3M Q2 '24: -70.8M Q3 '24: -111M Q4 '24: -117.7M Q1 '25: -93.7M Q2 '25: -36.9M Q3 '25: -7.4M Q4 '25: 732K Q1 '26: 46.3M Q2 '26: 30.1M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue TTM

0 600M 1.2B 1.8B Q4 '18: 830M Q1 '19: 802.6M Q2 '19: 802.4M Q3 '19: 798.7M Q4 '19: 794.3M Q1 '20: 805.9M Q2 '20: 794.6M Q3 '20: 810.3M Q4 '20: 809.5M Q1 '21: 807.7M Q2 '21: 808.7M Q3 '21: 812.4M Q4 '21: 824.8M Q1 '22: 993.7M Q2 '22: 1.2B Q3 '22: 1.4B Q4 '22: 1.6B Q1 '23: 1.6B Q2 '23: 1.5B Q3 '23: 1.5B Q4 '23: 1.5B Q1 '24: 1.5B Q2 '24: 1.6B Q3 '24: 1.6B Q4 '24: 1.6B Q1 '25: 1.6B Q2 '25: 1.5B Q3 '25: 1.5B Q4 '25: 1.4B Q1 '26: 1.3B Q2 '26: 1.3B Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Cash Flow TTM

-100M 0 100M 200M 300M Q4 '08: 30.3M Q1 '09: 45.4M Q2 '09: 47.1M Q3 '09: 49.2M Q4 '09: 51.1M Q1 '10: 41.6M Q2 '10: 40.9M Q3 '10: 29.7M Q4 '10: 33.1M Q1 '11: 38.1M Q2 '11: 41M Q3 '11: 50.3M Q4 '11: 64.5M Q1 '12: 67.7M Q2 '12: 70.5M Q3 '12: 69.4M Q4 '12: 66.3M Q1 '13: 58.7M Q2 '13: 60.8M Q3 '13: 67.6M Q4 '13: 65.7M Q1 '14: 67.7M Q2 '14: 69M Q3 '14: 71.8M Q4 '14: 66.3M Q1 '15: 66.9M Q2 '15: 66.2M Q3 '15: 66.6M Q4 '15: 64.2M Q1 '16: 68.2M Q2 '16: 76.8M Q3 '16: 84.3M Q4 '16: 89.9M Q1 '17: -4M Q2 '17: 19.3M Q3 '17: 91.1M Q4 '17: 154.4M Q1 '18: 210.3M Q2 '18: 242.2M Q3 '18: 194.8M Q4 '18: 160.2M Q1 '19: 159.9M Q2 '19: 103.5M Q3 '19: 103M Q4 '19: 101.9M Q1 '20: 162.4M Q2 '20: 168.4M Q3 '20: 193.1M Q4 '20: 222.8M Q1 '21: 234.6M Q2 '21: 260.1M Q3 '21: 263.4M Q4 '21: 267.5M Q1 '22: 214.9M Q2 '22: 98.7M Q3 '22: 22.2M Q4 '22: -62.1M Q1 '23: -19.5M Q2 '23: 40.4M Q3 '23: 73.2M Q4 '23: 166.2M Q1 '24: 170.7M Q2 '24: 254.2M Q3 '24: 255.1M Q4 '24: 204M Q1 '25: 209.6M Q2 '25: 138.8M Q3 '25: 159.4M Q4 '25: 179.8M Q1 '26: 167.4M Q2 '26: 236.4M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Free Cash Flow TTM

-210M -140M -70M 0 70M 140M 210M Q4 '08: 19M Q1 '09: 35.5M Q2 '09: 36.1M Q3 '09: 37.4M Q4 '09: 34.4M Q1 '10: 16.6M Q2 '10: 19.8M Q3 '10: 5.5M Q4 '10: 9.9M Q1 '11: 20.3M Q2 '11: 19.4M Q3 '11: 31.1M Q4 '11: 48.7M Q1 '12: 53.1M Q2 '12: 56.2M Q3 '12: 54.1M Q4 '12: 47.1M Q1 '13: 37.3M Q2 '13: 38M Q3 '13: 46.4M Q4 '13: 47.3M Q1 '14: 49.2M Q2 '14: 49.7M Q3 '14: 53.7M Q4 '14: 49.7M Q1 '15: 53.8M Q2 '15: 57.4M Q3 '15: 57.2M Q4 '15: 51.2M Q1 '16: 53.6M Q2 '16: 59.7M Q3 '16: 64M Q4 '16: 66.6M Q1 '17: -39.8M Q2 '17: -22.1M Q3 '17: 31.1M Q4 '17: 79.9M Q1 '18: 125.7M Q2 '18: 147.6M Q3 '18: 97M Q4 '18: 67.5M Q1 '19: 65.1M Q2 '19: 9.4M Q3 '19: 12.1M Q4 '19: 4.6M Q1 '20: 68.3M Q2 '20: 81.3M Q3 '20: 106.7M Q4 '20: 130.7M Q1 '21: 154M Q2 '21: 176.9M Q3 '21: 187.3M Q4 '21: 199M Q1 '22: 136.8M Q2 '22: 11.8M Q3 '22: -68.6M Q4 '22: -152.4M Q1 '23: -100.5M Q2 '23: -34.4M Q3 '23: -2.3M Q4 '23: 82.3M Q1 '24: 85.1M Q2 '24: 167.4M Q3 '24: 169.9M Q4 '24: 124.7M Q1 '25: 131.5M Q2 '25: 60.5M Q3 '25: 72M Q4 '25: 91.8M Q1 '26: 82.7M Q2 '26: 152.8M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q1 '08: 14.4M Q2 '08: 14.4M Q3 '08: 14.7M Q1 '09: 14.9M Q2 '09: 15.1M Q3 '09: 15.1M Q1 '10: 14.1M Q2 '10: 13.7M Q3 '10: 13.8M Q1 '11: 14.1M Q2 '11: 14.3M Q3 '11: 14.2M Q1 '12: 14.3M Q2 '12: 14.6M Q3 '12: 14.8M Q1 '13: 15.1M Q2 '13: 15.2M Q3 '13: 15.3M Q1 '14: 15.4M Q2 '14: 15.4M Q3 '14: 15.5M Q1 '15: 16.2M Q2 '15: 16.4M Q3 '15: 16.6M Q1 '16: 16.9M Q2 '16: 17M Q3 '16: 17.3M Q1 '17: 19.5M Q2 '17: 19.8M Q3 '17: 21.1M Q1 '18: 21.4M Q2 '18: 21.6M Q3 '18: 21.6M Q1 '19: 21.6M Q2 '19: 21.5M Q3 '19: 21.5M Q1 '20: 21.5M Q2 '20: 21.5M Q3 '20: 21.6M Q1 '21: 21.7M Q2 '21: 21.7M Q3 '21: 21.7M Q1 '22: 23.6M Q2 '22: 23.9M Q3 '22: 23.9M Q1 '23: 24M Q2 '23: 24.1M Q3 '23: 24.4M Q1 '24: 24.2M Q2 '24: 24.4M Q3 '24: 24.4M Q1 '25: 24.5M Q2 '25: 24.7M Q3 '25: 24.7M Q1 '26: 25.2M Q2 '26: 25M Q1 '10 Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '08: 1.66 Q1 '09: 1.93 Q2 '09: 1.98 Q3 '09: 1.88 Q4 '09: 1.67 Q1 '10: 1.50 Q2 '10: 1.68 Q3 '10: 1.91 Q4 '10: 2.21 Q1 '11: 2.48 Q2 '11: 2.59 Q3 '11: 2.59 Q4 '11: 3.15 Q1 '12: 3.11 Q2 '12: 3.07 Q3 '12: 3.24 Q4 '12: 2.80 Q1 '13: 2.85 Q2 '13: 2.70 Q3 '13: 2.60 Q4 '13: 2.64 Q1 '14: 2.49 Q2 '14: 2.39 Q3 '14: 2.09 Q4 '14: 1.69 Q1 '15: 1.86 Q2 '15: 2.31 Q3 '15: 2.87 Q4 '15: 2.74 Q1 '16: 3.22 Q2 '16: 3.37 Q3 '16: 3.48 Q4 '16: 3.69 Q1 '17: 5.47 Q2 '17: 2.62 Q3 '17: 1.54 Q4 '17: 3.33 Q1 '18: 0.70 Q2 '18: 4.01 Q3 '18: 4.01 Q4 '18: 1.32 Q1 '19: 2.53 Q2 '19: 2.15 Q3 '19: 3.38 Q4 '19: 4.70 Q1 '20: 4.04 Q2 '20: 3.86 Q3 '20: 3.78 Q4 '20: 4.03 Q1 '21: 4.34 Q2 '21: 4.77 Q3 '21: 5.04 Q4 '21: 4.74 Q1 '22: 2.04 Q2 '22: 0.42 Q3 '22: -1.56 Q4 '22: -3.11 Q1 '23: -1.91 Q2 '23: -2.01 Q3 '23: -1.16 Q4 '23: -1.23 Q1 '24: -2.45 Q2 '24: -2.92 Q3 '24: -4.57 Q4 '24: -4.84 Q1 '25: -3.84 Q2 '25: -1.53 Q3 '25: -0.32 Q4 '25: 0.03 Q1 '26: 1.86 Q2 '26: 1.19 Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.